LIVE PROGRAM
Join Our Mailing List
KEY DEADLINES
Abstract Submission Deadline: CLOSED
Early Bird Registration Deadline: CLOSED
Accommodation Deadline: 25 April 2021
Standard Registration Deadline: 16 May 2021
The committee are pleased to announce the LIVE Program is now available. This will continue to be updated as more details are confirmed, please note this is subject to change without notice. Please be aware the program is set AEST.
8.00am
Registration Opens
9.10am – 11.00am
Opening Ceremony & Invited Speaker Session 01
9.10am – 9.15am
9.15am – 9.20am
9.20am – 9.25am
9.25am – 9.30am
9.30am – 9.50am
9.50am – 10.10am
10.10am – 10.30am
10.30am – 11.00am
11.00am – 11.05am
Welcome to Country
Speaker: Shannon Ruska
Committee Welcome
Speaker: Kevin Marriott, Hepatitis Australia, QLD
Community Welcome
Speaker: Thomas Tu, University Of Sydney and Westmead Institute for Medical Research, NSW
Government Welcome
Speaker: Hon Yvette D’Ath, Minister for Health and Ambulance Services, QLD
Using data linkage to better understand progress towards viral elimination targets
Speaker, Jennifer MacLachlan, The Doherty Institute, VIC
Stigma and discrimination
Speaker: Timothy Broady, Centre for Social Research in Health, UNSW, NSW
Mental Health
Speaker: Megan Hughes, Sexual Health Services Tasmania, TAS
Q&A
Hepatitis Australia Statement
Carrie Fowlie, Hepatitis Australia, ACT
11.00am – 11.30am
Morning Tea
11.30am – 1.00pm
Plenary 01
11.30am – 12.00pm
12.00pm – 12.30pm
12.30pm – 12.45pm
12.45pm – 1.00pm
Keynote Presentation 01: Taking stock of HBV elimination efforts: Where are we now and what are the challenges for the future?
Speaker: Yusuke Shimakawa, Senior epidemiologist, Emerging Disease Epidemiology Unit, Institut Pasteur, Paris, France
Keynote Presentation 02: Hepatitis B in the CALD Community
Speaker: Zihong Gu, Program Manager, HIV, Hepatitis and Sexual Health Program at the Ethnic Communities Council of Queensland, Brisbane, QLD
Outcomes of the CT2 Study: A ‘One-Stop-Shop’ for Community-Based, General Practitioner-Led Hepatitis C Point-of-Care Testing and Treatment in Yangon, Myanmar
Speaker: Bridget Draper, Burnet Institute, VIC
Hepatitis C micro-elimination in mental health settings using a nurse led model of care
Speaker: Kristen McKee, Storr Liver Centre, Westmead Hospital, NSW
1.00pm – 2:00pm
Lunch
1:15pm – 1:55pm
Hepatitis B s100 Case Discussion
Open to HBV s100 Prescribers only. To register please contact Jane Teiken: jane.tieken@ashm.org.au, M: 0411 536 307
2.00pm – 3.30pm
Proffered Paper Session 01
2.00pm – 2.15pm
2.15pm – 2.30pm
2.30pm – 2.45pm
2.45pm – 3.00pm
3.00pm – 3.05pm
3.05pm – 3.10pm
3.10pm – 3.15pm
3.15pm – 3.20pm
3.20pm – 3.25pm
3.25pm – 3.30pm
Uptake of Perinatal Immunoprophylaxis for Infants Born to Women with a Record of Hepatitis B in Victoria (2009 – 2017)
Speaker: Anna Deng, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, VIC
How do Mothers with Chronic Hepatitis B Understand and Experience the Prevention of Mother to Child Transmission Interventions in Victoria?
Speaker: Nafisa Yussf, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, VIC
Interrupted Progress: Decline in Viral Hepatitis Testing and Care During Covid-19
Speaker: Jennifer MacLachlan, The Doherty Institute, VIC
Tasmanian eliminate hepatitis c Australian outreach project (TEHCAO)
Speaker: Megan Hughes, Sexual Health Services Tasmania, TAS
Analysing the Effects of HBV Splice Variants on Wildtype HBV Replication
Speaker: Laura McCoullough, Victorian Infectious Diseases Reference Laboratory, VIC
An Updated Estimate of the Annual Number of New Hepatitis C Infections Among People Who Inject Drugs in Australia
Speaker: Anna Palmer, Burnet Institute, VIC
Data Linkage for Surveillance of Newly Acquired Hepatitis C Infections in Queensland: Early Findings and Implications for Policy and Practice
Speaker: Damin Si, Queensland Department Of Health, QLD
Just a GP, Just a Finger Prick, Just an Hour
Speaker: Joss O’loan, Kombi Clinic, QLD
Beyond the C: Hepatitis C Elimination in Your Practice
Speaker: Olivia Dawson, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, NSW
Palen Creek Prison Cures; HCV Elimination in a Weekend
Speaker: Joss O’loan, Kombi Clinic, QLD
3.30pm – 4.00pm
Afternoon Tea
4.00pm – 5.30pm
Invited Speaker Session 02
4.00pm – 4.20pm
4.20pm – 4.40pm
4.40pm – 5.00pm
5.00pm – 5.30pm
Addressing viral hepatitis in regional and remote settings
Speaker: Jane Davies, Menzies School of Health Research, NT
Engaging CALD communities with testing, monitoring and care for hepatitis B and C
Speaker: Jack Wallace, The Burnet Institute, VIC
Homelessness
Speaker: Mary-Anne Rushford, Bolton Clarke, VIC
Q&A
5.30pm – 6.15pm
Fit for purpose? HCV notification in the post DAA world
Chair: Linda Selvey, The University of Queensland
Panellists: Nik Alexander, Queensland Injectors Health Network (QuiHN), QLD, Greg Dore, The Kirby Institute, UNSW Sydney, Margaret Hellard, Burnet Insitute, VIC, Stephen Lambert, The University of Queensland, QLD
5.30pm – 6.00pm
Networking Drinks
8.00am
Registration Opens
8.30am – 11.15am
Invited Speaker Session 03
8.25am – 8.30am
8.30am – 8.35am
8.35am – 8.40am
8.40am – 8.45am
8.45am – 9.05am
9.05am – 9.25am
9.25am – 9.45am
9.45am – 10.15am
10.15am – 10.45am
Welcome to Country
Speaker: Yvonne Weldon
Committee Welcome
Speaker: Mark Stoove, Burnet Institute
Community Welcome
Speaker: Pamela Wood, Hepatitis Australia, VIC
Government Welcome
Leveraging learnings from Australian point-of-care testing networks to inform scale-up of hepatitis C RNA testing
Speaker: Susan Matthews, International Centre for Point of Care Testing, SA
Patient perspectives on testing methods
Speaker: Esha Leyden, Queensland Injectors Health Network, QLD
Linkage to care and sustainability of models
Speaker: Marianne Martinello, The Kirby Institute, UNSW, NSW
Q&A
Connecting with care
Speaker: Conor Ashleigh, Digital Storyteller
10.45am – 11.15am
Morning Tea
11.15am – 1.00pm
Plenary 02
11.30am – 12.00pm
11.45am – 12.15pm
12.15pm – 12.30pm
12.30pm – 12.45pm
12.45pm – 1.00pm
Keynote Presentation 03: Taking stock of HCV elimination efforts: Where are we now and what are the challenges for the future?
Speaker: Natasha Martin, University of California San Diego, USA
Keynote Presentation 04: Community perspective: how are we are actually engaging people in treatment and management for viral hepatitis
Speaker: Chris Gough, Executive Director of the Canberra Alliance for Harm Minimisation and Advocacy (CAHMA) and The Connection health service, Canberra, ACT
Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the Stop-C Study
Speaker: Behzad Hajarizadeh, The Kirby Institute, UNSW Sydney, NSW
The C-LINK trial: a prospective randomised controlled trial showing that care-navigation post release from prisons increases linkage to hepatitis C care
Speaker: Alex Thompson, St Vincent’s Hospital Melbourne, VIC
The Levinia Crooks Emerging Leader Award Presentation
1.00pm – 2.00pm
Lunch
1.15pm – 2.00pm
Cepheid Symposium
2.00pm – 3.30pm
Proffered Paper Session 02
2.00pm – 2.15pm
2.15pm – 2.30pm
2.30pm – 2.45pm
2.45pm – 3.00pm
3.00pm – 3.05pm
3.05pm – 3.10pm
3.10pm – 3.15pm
3.15pm – 3.20pm
3.20pm – 3.25pm
3.25pm – 3.30pm
Interventions to Enhance Testing and Treatment Uptake for Hepatitis C Infection: A Systematic Review and Meta-Analysis
Speaker: Evan Cunningham, The Kirby Institute, UNSW Sydney, NSW
Hepatitis C Testing and Gaining Informed Consent: Taking Stock and Innovating for the Future
Speaker: Emily Lenton, Australian Research in Sex, Health and Society, VIC
Point-of-care HCV RNA testing, linkage to nursing care, and peer-supported engagement and delivery to enhance HCV treatment among people with recent injecting drug use at a community-led needle and syringe program: the TEMPO pilot study
Speaker: Jason Grebely, The Kirby Institute, UNSW Sydney, NSW
Rapid point of care HCV testing allows high throughput HCV screening and rapid treatment uptake among PWID attending a medically supervised injecting room
Speaker: Michael Macisaac, St Vincent’s Hospital Melbourne, VIC
Sentinel Surveillance of Hepatitis Cc Antibody Testing, Victoria, Australia, 2009 to 2019
Speaker: Anna Wilkinson, Burnet Institute, VIC
Slipping Through the Cracks? The Efficacy of Opt-Out HCV Testing in a Primary Health Care Facility Serving Marginalised Populations
Speaker: Edmund Silins, Kirketon Road Centre, NSW
Exploring the Potential use of Notification Data to Increase Hepatitis C Treatment Uptake
Speaker: Shelley Walker, Burnet Institute, VIC
Prison Transition Program, a Community-Based Program; that Facilitates the Continuity of Care for Clients in Different Phases of HCV Treatment Among People Transitioning in or Out of Correctional Centre in South East
Speaker: Dorrit Grimstrup, QuIHN, QLD
Evaluation of the ‘Peers Assisting Treatment of Hepatitis C’ (PATH) Model in a Primary Care Setting in Melbourne, Australia
Speaker: Carolyn Weidner, Harm Reduction Victoria, Melbourne, VIC
Jurisdictional Disparities in Progress Towards Improving the Cascade of Care for Chronic Hepatitis B in Australia
Speaker: Karen McCulloch, WHO Collaborating Centre For Viral Hepatitis, Doherty Institute, VIC
3.30pm – 4.00pm
Afternoon Tea
4.00pm – 5.30pm
Invited Speaker Session 04
4.00pm – 4.20pm
4.20pm – 4.40pm
4.40pm – 5.00pm
5.00pm – 5.30pm
Nursing and viral hepatitis care
Speaker: Sinead Sheils, Royal Prince Alfred Hospital Gastroenterology & Liver, NSW
Advances in antiviral therapy for HBV infection
Speaker: Peter Revill, The Doherty Institute, VIC
Adapting to COVID-19
Speaker: Phill Read, Kirketon Road Centre, NSW
Q&A
5.35pm – 6.05pm
Networking Drinks
9.00am
Registration Opens
9.10am – 10.45am
Invited Speaker Session 05
9.10am – 9.30am
9.30am – 9.50am
9.50am – 10.10am
10.10am – 10.40am
10.40am – 10.45am
How much will it cost to eliminate viral hepatitis?
Speaker: Nick Scott, Burnet Institute, VIC
Prisons
Speaker: Colette McGrath, Justice Health, NSW
Government and policy maker role in elimination
Speaker: Stuart Manoj-Margison, Australian Government Department of Health, ACT
Q&A
Hepatitis Australia Statement
10.45am – 11.15am
Morning Tea
11.15am – 12.45pm
Plenary 03
11.15am – 11.45am
11.45am – 12.15pm
12.15pm – 12.30pm
12.30pm – 12.45pm
Keynote Presentation 05: Success and challenges in addressing viral hepatitis in the Asia-Pacific
Speaker: Saeed Sadiq Hamid, Professor, Department of Medicine and Director of the Clinical Trials Unit, The Aga Khan University, Karachi, Pakistan
Keynote Presentation 06
Development, Delivery and Evaluation of a Culturally Safe Hepatitis B Management Education Course for the Aboriginal Workforce to Increase Access and Reduce Health Inequity
Speaker: Kelly Hosking & Phillip Wilson, Menzies School of Health Research, NT
Hepatitis C Imaginaries: Findings from a New Study on Stigma, Discrimination and Post-Cure Lives
Speaker: Kate Seear, La Trobe University, VIC
12.45pm – 1.45pm
Lunch
1.45pm – 2.45pm
Proffered Paper Session 03
1.45pm – 2.00pm
2.00pm – 2.15pm
2.15pm – 2.30pm
2.30pm – 2.45pm
2.45pm – 2.50pm
2.50pm – 2.55pm
2.55pm – 3.00pm
3.00pm – 3.05pm
3.05pm – 3.10pm
3.10pm – 3.15pm
Identifying Enablers that Facilitate Hepatitis B Clinical Management in Primary Care Settings
Speaker: Jack Wallace, Burnet Institute, VIC
Quantifying Nurses Contribution to HCV Care Milestones: Findings from an Integrated Primary Healthcare Setting for Marginalised People
Speaker: Edmund Silins, Kirketon Road Centre, NSW
“We’ve had a Circuit Breaker for an Old Dogma of More Than 20 Years”: Changes to Opioid Agonist Treatment Services During COVID-19, the CHOICE Study
Speaker: Anna Conway, The Kirby Institute, UNSW Sydney, NSW
A Hidden Population: Supporting Healthy Ageing for People Who Inject Drugs
Speaker: Harini Walthati, AIVL, ACT
A Qualitative Exploration of Enablers to Hepatitis B Clinical Management Among Ethnic Chinese in Australia
Speaker: Yinzong Xiao, Burnet Institute, VIC
Find the Hero Inside You: World Hepatitis Day Digital Campaign
Speaker: Samantha White, Hepatitis Queensland, QLD
A Costing Analysis of a State-Wide, Nurse-Led Hepatitis C Treatment Model in Prison
Speaker: Anna Palmer, Burnet Institute, VIC
A Culturally Appropriate Evaluation of the “Hep B Story” App in a Remote Australian Community in Arnhem Land
Speaker: Paula Binks & George Gurruwiwi, Menzies School Of Health Research, NT
Violence and Hepatitis C Transmission in Prison – A Modified Social Ecological Model
Speaker: Hossain Sazzad, The Kirby Institute, UNSW Sydney, NSW
Reinfection in the Reach-C Cohort: Occurrence and Effectiveness of Retreatment for Hepatitis C Virus Reinfection Following Direct Acting Antiviral Therapy
Speaker: Joanne Carson, UNSW, NSW
3.15pm – 3.45pm
Afternoon Tea
3.45pm – 4.45pm
Closing Plenary
3.45pm – 4.30pm
4.30pm – 4.45pm
Panel Discussion
Conference closing remarks
Speaker: Alexis Apostolellis, Chief Executive Officer, The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, NSW